Statutory Rules
1979 No. 35
REGULATIONS UNDER THE HEALTH INSURANCE ACT 19731
I, THE GOVERNOR-GENERAL of the Commonwealth of Australia acting with the advice of the Federal Executive Council, hereby make the following Regulations under the Health Insurance Act 1973.
Dated this first day of March 1979.
ZELMAN COWEN
Governor-General
By His Excellency’s Command,
RALPH J. HUNT
Minister of State for Health
–––––––––
HEALTH INSURANCE (VARIATION OF FEES AND MEDICAL SERVICES) (No. 12) REGULATIONS
Citation
1. These Regulations may be cited as the Health Insurance (Variation of Fees and Medical Services) (No. 12) Regulations.
Commencement
2. These Regulations shall come into operation on 5 March 1979.
Health Insurance (Variation of Fees and Medical Services) (No. 7) Regulations— amendment of Schedule
3. The Schedule to the Health Insurance (Variation of Fees and Medical Services) (No. 7) Regulations (being that Schedule as amended by the Health Insurance (Variation of Fees and Medical Services) (No. 8) Regulations, the Health Insurance (Variation of Fees and Medical Services) (No. 9) Regulations, the Health Insurance (Variation of Fees and Medical Services) (No. 10) Regulations and the Health Insurance (Variation of Fees and Medical Services) (No. 11) Regulations) is amended by omitting Part 7 of the table of medical services and substituting the following Part:
“PART 7—PATHOLOGY SERVICES
Item No. |
|
|
| Fees |
|
|
|
Medical service | N.S.W. | Vic. | Qld | S.A. | W.A. | Tas. | |
|
| $ | $ | $ | $ | $ | $ |
“Division 1—Haematology | |||||||
“1006 | Blood count consisting of erythrocyte count, erythrocyte sedimentation rate, haematocrit estimation, haemoglobin estimation, platelet count or leucocyte count—one procedure (SP) | 3.20 | 3.20 | 3.20 | 3.20 | 3.20 | 3.20 |
“1007 | Blood count consisting of erythrocyte count, erythrocyte sedimentation rate, haematocrit estimation, haemoglobin estimation, platelet count or leucocyte count—one procedure (excluding blood count consisting of haemoglobin estimation or erythrocyte sedimentation rate when not referred by another medical practitioner) (OP) | 2.40 | 2.40 | 2.40 | 2.40 | 2.40 | 2.40 |
“1008 | 2 procedures to which item 1006 applies (SP).. | 5.10 | 5.10 | 5.10 | 5.10 | 5.10 | 5.10 |
“1009 | 2 procedures to which item 1007 applies (OP).. | 3.85 | 3.85 | 3.85 | 3.85 | 3.85 | 3.85 |
“1010 | Blood count consisting of erythrocyte count, erythrocyte sedimentation rate, haematocrit estimation, haemoglobin estimation, platelet count or leucocyte count—two procedures (excluding blood count consisting of haemoglobin estimation or erythrocyte sedimentation rate when not referred by another medical practitioner) (HP) | 3.25 | 3.25 | 3.25 | 3.25 | 3.25 | 3.25 |
“1011 | 3 or more procedures to which item 1006 applies including calculation of erythrocyte indices where done (SP) | 7.70 | 7.70 | 7.70 | 7.70 | 7.70 | 7.70 |
“1012 | 3 or more procedures to which item 1007 applies including calculation of erythrocyte indices where done (OP) | 5.80 | 5.80 | 5.80 | 5.80 | 5.80 | 5.80 |
“1013 | 3 or more procedures to which item 1010 applies, including calculation of erythrocyte indices where done (HP) | 3.85 | 3.85 | 3.85 | 3.85 | 3.85 | 3.85 |
“1014 | Blood film, examination of—including erythrocyte morphology, differential count by one or more methods and the qualitative estimation of platelets (SP) | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 |
“1015 | Blood film, examination of—including erythrocyte morphology, differential count by one or more methods and the qualitative estimation of platelets (OP) | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 |
“1016 | Blood film, examination of—including erythrocyte morphology, differential count by one or more methods and the qualitative estimation of platelets (HP) | 3.20 | 3.20 | 3.20 | 3.20 | 3.20 | 3.20 |
“1019 | Blood film, examination by special stains to demonstrate the presence of basophilic stippling, eosinophils (where wet preparation or film is used), haemoglobin H, reticulocytes or similar conditions, cells or substances-one procedure (SP) | 2.60 | 2.60 | 2.60 | 2.60 | 2.60 | 2.60 |
| Fees | ||||||
Item No. | Medical service | N.S.W. | Vic. | Qld | S.A. | W.A. | Tas. |
|
| $ | $ | $ | $ | $ | $ |
“1020 | Blood film, examination by special stains to demonstrate the presence of basophilic stippling, eosinophils (where wet preparation or film is used), haemoglobin H, reticulocytes, or similar conditions, cells or substances—one procedure (OP) | 1.95 | 1.95 | 1.95 | 1.95 | 1.95 | 1.95 |
“1021 | 2 or more procedures to which item 1019 applies (SP) | 3.90 | 3.90 | 3.90 | 3.90 | 3.90 | 3.90 |
“1022 | 2 or more procedures to which item 1020 applies (OP) | 2.95 | 2.95 | 2.95 | 2.95 | 2.95 | 2.95 |
“1028 | Blood film, examination by special stains to demonstrate the presence of foetal haemoglobin, Heinz bodies, iron, malarial or other parasites, neutrophil alkaline phosphatase, PAS, Sudan black positive granules, sickle cells, or any similar cells, substances or parasites-one procedure (SP) | 3.90 | 3.90 | 3.90 | 3.90 | 3.90 | 3.90 |
“1029 | Blood film, examination by special stains to demonstrate the presence of foetal haemoglobin, Heinz bodies, iron, malarial or other parasites, neutrophil alkaline phosphatase, PAS, Sudan black positive granules, sickle cells, or any similar cells, substances or parasites-one procedure (OP) | 2.95 | 2.95 | 2.95 | 2.95 | 2.95 | 2.95 |
“1030 | 2 or more procedures to which item 1028 applies (SP) | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 |
“1032 | 2 or more procedures to which item 1029 applies (OP) | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 |
“1036 | Erythrocytes, qualitative assessment of metabolism or haemolysis by— erythrocyte autohaemolysis test, erythrocyte fragility test (mechanical), glucose-6-phosphate dehydrogenase estimation, glutathione deficiencies test, pyruvate kinase estimation or sugar water test (or similar) for paroxysmal nocturnal haemoglobinuria—one procedure (SP) | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 |
“1037 | Erythrocytes, qualitative assessment of metabolism or haemolysis by— erythrocyte autohaemolysis test, erythrocyte fragility test (mechanical), glucose-6-phosphate dehydrogenase estimation, glutathione deficiencies test, pyruvate kinase estimation or sugar water test (or similar) for paroxysmal nocturnal haemoglobinuria— one procedure (OP) | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 |
“1038 | 2 or more procedures to which item 1036 applies (SP) | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 |
“1040 | 2 or more procedures to which item 1037 applies (OP) | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 |
| Fees | ||||||
Item No. | Medical service | N.S.W. | Vic. | Qld | S.A. | W.A. | Tas. |
|
| $ | $ | $ | $ | $ | $ |
“1044 | Erythrocytes, quantitative assessment of metabolism or haemolysis by-acid haemolysis test (or similar) for paroxysmal nocturnal haemoglobinuria, erythrocyte fragility to hypotonic saline test without incubation, erythrocyte fragility to hypotonic saline test after incubation, glutathione stability test, glucose-6-phosphate dehydrogenase estimation or pyruvate kinase estimation -one procedure (SP) | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 |
“1045 | Erythrocytes, quantitative assessment of metabolism or haemolysis by-acid haemolysis test (or similar) for paroxysmal nocturnal haemoglobinuria, erythrocyte fragility to hypotonic saline test without incubation, erythrocyte fragility to hypotonic saline test after incubation, glutathione stability test, glucose-6-phosphate dehydrogenase estimation or pyruvate kinase estimation-one procedure (OP) | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 |
“1048 | 2 or more procedures to which item 1044 applies (SP) | 25.50 | 25.50 | 25.50 | 25.50 | 25.50 | 25.50 |
“1049 | 2 or more of any procedures to which item 1045 applies (OP) | 19.15 | 19.15 | 19.15 | 19.15 | 19.15 | 19.15 |
“Bone Marrow Examination | |||||||
“1062 | Bone marrow examination (including use of special stains where indicated) of bone marrow aspirate, clot section or trephine section-one procedure (SP) | 38.50 | 38.50 | 38.50 | 38.50 | 38.50 | 38.50 |
“1063 | Bone marrow examination (including use of special stains where indicated) of bone marrow aspirate, clot section or trephine section-one procedure (OP) | 28.90 | 28.90 | 28.90 | 28.90 | 28.90 | 28.90 |
“1064 | 2 or more procedures to which item 1062 applies (SP) | 64.00 | 64.00 | 64.00 | 64.00 | 64.00 | 64.00 |
“1065 | 2 or more procedures to which item 1063 applies (OP) | 48.00 | 48.00 | 48.00 | 48.00 | 48.00 | 48.00 |
"Blood Transfusion Procedures | |||||||
“1080 | Blood grouping (including back grouping when performed)-ABO and Rh (D antigen) (not covered by item 1089) (SP) | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 |
“1081 | Blood grouping (including back grouping when performed)-ABO and Rh (D antigen) (not covered by item 1090) (OP) | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 |
“1089 | Blood grouping (including back grouping when performed)-ABO and Rh (D antigen) when performed in association with the compatibility testing covered by item 1112 or 1114 (SP) | 11.60 | 11.60 | 11.60 | 11.60 | 11.60 | 11.60 |
“1090 | Blood grouping (including back grouping when performed)-ABO and Rh (D antigen) when performed in association with the compatibility testing covered by item 1113 or 1116 (OP) | 8.70 | 8.70 | 8.70 | 8.70 | 8.70 | 8.70 |
|
|
|
| Fees |
|
|
|
Item No. | Medical service | N.S.W. | Vic. | Qld | S.A. | W.A. | Tas. |
|
| $ | $ | $ | $ | $ | $ |
“1101 | Blood grouping—for Rh phenotypes or grouping by the Kell, Duffy or any other blood group system—one procedure (SP) | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 |
“1102 | Blood grouping—for Rh phenotypes or grouping by the Kell, Duffy or any other blood group system—one procedure (OP) | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 |
“1104 | 2 procedures to which item 1101 applies (SP) | 25.50 | 25.50 | 25.50 | 25.50 | 25.50 | 25.50 |
“1105 | 2 procedures to which item 1102 applies (OP ) | 19.15 | 19.15 | 19.15 | 19.15 | 19.15 | 19.15 |
“1106 | Each procedure to which item 1101 applies in excess of 2 (SP) | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 |
“1108 | Each procedure to which item 1102 applies in excess of 2 (OP) | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 |
“1111 | Compatibility testing (by saline, papain, albumin or indirect Coombs techniques), including auto-crossmatch and donor group check where performed—testing involving one or two units of blood (SP) | 25.50 | 25.50 | 25.50 | 25.50 | 25.50 | 23-50 |
“1112 | Compatibility testing (by saline, papain, albumin or indirect Coombs techniques), including auto-crossmatch and donor group check where performed—testing involving one or two units of blood (OP) | 19.15 | 19.15 | 19.15 | 19.15 | 19.15 | 19.15 |
“1113 | Compatibility testing (by saline, papain, albumin or indirect Coombs techniques), including auto-crossmatch and donor group check where performed—testing involving one or two units of blood (HP) | 12.75 | 12.75 | 12.75 | 12.75 | 12.75 | 12.75 |
“1114 | Compatibility testing (by saline, papain, albumin or indirect Coombs techniques), including auto-crossmatch and donor group check where performed—each unit of blood tested in excess of 2 (SP) | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 |
“1116 | Compatibility testing (by saline, papain, albumin or indirect Coombs techniques), including auto-crossmatch and donor group check where performed—each unit of blood tested in excess of 2 (OP) | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 |
“1117 | Compatibility testing (by saline, papain, albumin or indirect Coombs techniques), including auto-crossmatch and donor group check where performed—each unit of blood tested in excess of 2 (HP) | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 |
“1121 | Examination of serum for Rh antibodies or other blood group antibodies or both Rh antibodies and other blood group antibodies—screening test (including all indicated techniques) (SP) | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 |
“1122 | Examination of serum for Rh antibodies or other blood group antibodies or both Rh antibodies and other blood group antibodies—screening test (including all indicated techniques) (OP) | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 |
|
|
|
| Fees |
|
|
|
Item No. | Medical service | N.S.W. | Vic. | Qld | S.A. | W.A. | Tas. |
|
| $ | $ | $ | $ | $ |
|
“1124 | Examination of serum for Rh antibodies or other blood group antibodies or both Rh antibodies and other blood group antibodies—screening test (including all indicated techniques) and quantitative estimation of one antibody (SP) | 25.50 | 25.50 | 25.50 | 25.50 | 25.50 | 25.50 |
“1125 | Examination of serum for Rh antibodies or other blood group antibodies or both Rh antibodies and other blood group antibodies—screening test (including all indicated techniques) and quantitative estimation of one antibody (OP) | 19.15 | 19.15 | 19.15 | 19.15 | 19.15 | 19.15 |
“1126 | Examination of serum for Rh antibodies or other blood group antibodies or both Rh antibodies and other blood group antibodies—quantitative estimation of one antibody (SP) | 19.20 | 19.20 | 19.20 | 19.20 | 19.20 | 19.20 |
“1128 | Examination of serum for Rh antibodies or other blood group antibodies or both Rh antibodies and other blood group antibodies—quantitative estimation of one antibody (OP) | 14.40 | 14.40 | 14.40 | 14.40 | 14.40 | 14.40 |
“1129 | Examination of serum for Rh antibodies or other blood group antibodies or both Rh antibodies and other blood group antibodies—quantitative estimation of each antibody in excess of one (SP) | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 |
“1130 | Examination of serum for Rh antibodies or other blood group antibodies or both Rh antibodies and other blood group antibodies—quantitative estimation of each antibody in excess of one (OP) | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 |
“1136 | Coombs test, direct (SP)............. | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 |
“1137 | Coombs test, direct (OP)............. | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 |
“1144 | Coombs test, indirect (not associated with item 1112, 1114, 1121, 1124, 1126 or 1129 except where part of neo-natal screening or in investigation of haemolytic anaemia) (SP) | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 |
“1145 | Coombs test, indirect (not associated with item 1113, 1116, 1122, 1125, 1128 or 1130 except where part of neo-natal screening or in investigation of haemolytic anaemia) (OP) | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 |
“1152 | Examination of serum for blood group haemolysins (SP) | 12.80 1 | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 |
“1153 | Examination of serum for blood group haemolysins (OP) | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 |
“1159 | Leucocyte agglutinins, detection of (SP)... | 12.80 1 | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 |
“1160 | Leucocyte agglutinins, detection of (OP)... | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 |
“1166 | Platelet agglutinins, detection of (SP)..... | 12.80 1 | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 |
“1167 | Platelet agglutinins, detection of (OP)..... | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 |
“1190 | Heterophile antibodies—qualitative estimation of (test for infectious mononucleosis) (SP) | 5.10 | 5.10 | 5.10 | 5.10 | 5.10 | 5.10 |
“1191 | Heterophile antibodies-qualitative estimation of (test for infectious mononucleosis) (OP) | 3.85 | 3.85 | 3.85 | 3.85 | 3.85 | 3.85 |
|
|
|
| Fees |
|
|
|
Item No. | Medical service | N.S.W. | Vic. | Qld | S.A. | W.A. | Tas. |
|
| $ | $ | $ | $ | $ | $ |
“1194 | Heterophile antibodies—quantitative estimation of by serial dilutions with specific absorption (including qualitative estimation covered by item 1190 where performed) (SP) | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 |
“1195 | Heterophile antibodies—quantitative estimation of by serial dilutions with specific absorption (including qualitative estimation covered by item 1191 where performed) (OP) | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 |
“1202 | Cold agglutinins, qualitative estimation of (SP) | 5.10 | 5.10 | 5.10 | 5.10 | 5.10 | 5.10 |
“1203 | Cold agglutinins, qualitative estimation of (OP) | 3.85 | 3.85 | 3.85 | 3.85 | 3.85 | 3.85 |
“1206 | Cold agglutinins, quantitative estimation of by serial dilutions (including qualitative estimation covered by item 1202 where performed) (SP) | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 |
“1207 | Cold agglutinins, quantitative estimation of by serial dilutions (including qualitative estimation covered by item 1203 where performed) (OP) | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 |
“1211 | Bipod volume, estimation of by dye method (SP) | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 |
“1212 | Blood volume, estimation of by dye method (OP) | 4.80 | 4.80 | 4.30 | 4.80 | 4.80 | 4.80 |
“1215 | Blood, spectroscopic examination of (SP)... | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 |
“1216 | Blood,, spectroscopic examination of (OP).. | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 |
“Haemostasis | |||||||
“1234 | Estimation of—bleeding time, coagulation time (including clot retraction), prothrombin time (one stage) or thromboplastin time (partial) with or without kaolin or kaolin clotting time-one procedure (SP) | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 |
“1235 | Estimation of—bleeding time, coagulation time (including clot retraction), prothrombin time (one stage) or thromboplastin time (partial) with or without kaolin or kaolin clotting time-one procedure (OP) | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 |
“1236 | 2 procedures to which item 1234 applies (SP) | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 |
“1237 | 2 procedures to which item 1235 applies (OP) | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 |
“1238 | 3 or more procedures to which item 1234 applies (SP) | 12.80 | 12.80 | 12.80 | 12.80 | 12.80, | 12.80 |
“1239 | 3 or more procedures to which item 1235 applies (OP) | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 |
“1242 | Platelet aggregation, qualitative test for (SP). | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 |
“1243 | Platelet aggregation, qualitative test for (OP). | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 |
“1244 | Estimation of thrombin time (including test for presence of an inhibitor and serial test for fibrinogenolysis) or recalcified plasma clotting time—each procedure (SP) | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 |
|
|
|
| Fees |
|
|
|
Item No. | Medical service | N.S.W. | Vic. | Qld | S.A. | W.A. | Tas. |
|
| $ | $ | $ | $ | $ | $ |
“1246 | Estimation of thrombin time (including test for presence of an inhibitor and serial test for fibrinogenolysis) or recalcified plasma clotting time—each procedure (OP) | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 |
“1247 | Fibrinogen litre, determination of (SP)...... | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 |
“1248 | Fibrinogen titre, determination of (OP)...... | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 |
“1251 | Factor 13, test for presence of (SP)......... | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 |
“1252 | Factor 13, test for presence of (OP)......... | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 |
“1255 | Thromboplastin generation screening test (SP). | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 | 9.60. |
“1256 | Thromboplastin generation screening test (OP). | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 |
“1259 | Prothrombin time, estimation of (two stage) (SP) | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 |
“1260 | Prothrombin time, estimation of (two stage) (OP) | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 |
“1263 | Quantitative estimation of—fibrin degeneration products, platelet adhesion, prothrombin consumption or protamine sulphate—each procedure (SP) | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 |
“1264 | Quantitative estimation of—fibrin degeneration products, platelet adhesion, prothrombin consumption or protamine sulphate—each procedure (OP) | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 |
“1267 | Euglobulin lysis time, estimation of (SP)..... | 19.20 | 19.20 | 19.20 | 19.20 | 19.20 | 19.20 |
“1268 | Euglobulin lysis time, estimation of (OP)..... | 14.40 | 14.40 | 14.40 | 14.40 | 14.40 | 14.40 |
“1271 | Quantitative estimation of platelet antibodies (by one or more techniques), platelet Factor III availability or one or more blood coagulation factors (including antihaemophilic globulin)— each procedure (SP) | 19.20 | 19.20 | 19.20 | 19.20 | 19.20 | 19.20 |
“1272 | Quantitative estimation of platelet antibodies (by one or more techniques), platelet Factor III availability or one or more blood coagulation factors (including antihaemophilic globulin)— each procedure (OP) | 14.40 | 14.40 | 14.40 | 14.40 | 14.40 | 14.40 |
“1277 | Platelet aggregation test using—ADP, collagen, 5HT, ristocetin, or similar substance—one procedure (SP) | 19.20 | 19.20 | 19.20 | 19.20 | 19.20 | 19.20 |
“1278 | Platelet aggregation test using—ADP, collagen, 5HT, ristocetin, or similar substance—one procedure (OP) | 14.40 | 14.40 | 14.40 | 14.40 | 14.40 | 14.40 |
“1279 | 2 or more procedures to which item 1277 applies (SP) | 38.50 | 38.50 | 38.50 | 38.50 | 38.50 | 38.50 |
“1280 | 2 or more procedures to which item 1278 applies (OP) | 28.90 | 28.90 | 28.90 | 28.90 | 28.90 | 28.90 |
“Division 2—Chemistry of Body Fluids and Tissues | |||||||
“1301 | Estimation by any method of—albumin, alkaline phosphatase, ALT, AST, bicarbonate, bilirubin (direct), bilirubin (indirect), calcium, chloride, cholesterol, CK, creatinine, GGTP, globulin, glucose, HBD, LD, phosphate, potassium, protein (total), sodium, triglycerides, urate or urea or estimation of a substance referred to in any other item in this Division other than items 1302 and 1303 where the estimation is performed on a multichannel analyser-one estimation (SP) | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 |
|
|
|
| Fees |
|
|
|
Item No. | Medical service | N.S.W. | Vic. | Qld | S.A. | W.A. | Tas. |
|
| $ | $ | $ | $ | $ | $ |
“1302 | Estimation by any method of-albumin, alkaline phosphatase, ALT, AST, bicarbonate, bilirubin (direct), bilirubin (indirect), calcium, chloride, cholesterol, CK, creatinine, GGTP, globulin, glucose, HBD, LD, phosphate, potassium, protein (total), sodium, triglycerides, urate or urea or estimation of a substance referred to in any other item in this Division other than items 1301 and 1303 where the estimation is performed on a multi- channel analyser-one estimation (OP) | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 |
“1303 | Estimation by any method of-albumin, alkaline phosphatase, ALT, AST, bicarbonate, bilirubin, (direct), bilirubin (indirect), calcium, chloride, cholesterol, CK, creatinine, GGTP, globulin, glucose, HBD, LD, phosphate, potassium, protein (total), sodium, triglycerides, urate or urea or estimation of a substance referred to in any other item in this Division other than items 1301 and 1302 where the estimation is performed on a multi- channel analyser-one estimation (HP) | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 |
“1304 | 2 estimations of a kind specified in item 1301 (SP) | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 |
“1305 | 2 estimations of a kind specified in item 1302 (OP) | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 |
“1306 | 2 estimations of a kind specified in item 1303 (HP) | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 |
“1307 | 3 to 5 estimations of a kind specified in item 1301 (SP) | 16.00 | 16.00 | 16.00 | 16.00 | 16.00 | 16.00 |
“1308 | 3 to 5 estimations of a kind specified in item 1302 (OP) | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 |
“1309 | 3 to 5 estimations of a kind specified in item 1303 (HP) | 8.00 | 8.00 | 8.00 | 8.00 | 8.00 | 8.00 |
“1310 | 6 or more estimations of a kind specified in item 1301 (SP) | 17.60 | 17.60 | 17.60 | 17.60 | 17.60 | 17.60 |
“1311 | 6 or more estimations of a kind specified in item 1302 (OP) | 13.20 | 13.20 | 13.20 | 13.20 | 13.20 | 13.20 |
“1312 | 6 or more estimations of a kind specified in item 1303 (HP) | 8.80 | 8.80 | 8.80 | 8.80 | 8.80 | 8.80 |
“1319 | Qualitative estimation of- acidity (by pH meter or titration), blood in faeces (occult blood), cryoglobulins, cryoproteins, euglobulins, macroglobulins (Sia test), PBG, UBG or any other substance not specified in any other item in this Division-one estimation (SP) | 3.20 | 3.20 | 3.20 | 3.20 | 3.20 | 3.20 |
“1320 | Qualitative estimation of- acidity (by pH meter or titration), blood in faeces (occult blood), cryoglobulins, cryoproteins, euglobulins, macroglobulins (Sia test), PBG, UBG or any other substance not specified in any other item in this Division-one estimation (OP) | 2.40 | 2.40 | 2.40 | 2.40 | 2.40 | 2.40 |
“1322 | 2 or more estimations to which item 1319 applies (SP) | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 |
“1323 | 2 or more estimations to which item 1320 applies (OP) | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 |
|
|
|
| Fees |
|
|
|
Item No. | Medical service | N.S.W. | Vic. | Qld | S.A. | W.A. | Tas. |
|
| $ | $ | $ | $ | $ | $ |
“1327 | Qualitative estimation of— foetoprotein, gastric acidity (by dye method) or porphyrins—each estimation (SP) | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 |
“1328 | Qualitative estimation of—foetoprotein, gastric acidity (by dye method) or porphyrins—each estimation (OP) | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 |
“1330 | Chromatography, qualitative estimation of a substance not specified in any other item in this Division (SP) | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 |
“1331 | Chromatography, qualitative estimation of a substance not specified in any other item in this Division (OP) | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 |
“1333 | Electrophoresis, qualitative (SP)......... | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 |
“1334 | Electrophoresis, qualitative (OP)......... | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 |
“1336 | Australia antigen or similar antigen, detection of by any method including radioimmunoassay (SP) | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 |
“1337 | Australia antigen or similar antigen, detection of by any method including radioimmunoassay (OP) | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 |
“1339 | Osmolality, estimation of in serum or urine (SP) | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 |
“1340 | Osmolality, estimation of in serum or urine (OP) | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 |
“1342 | Quantitative estimation of—acid phosphatase, aldolase, amylase, lipase, amylase and lipase, bromide, BSP, caeruloplasmin, carotene, complement fraction, any other specific protein (excluding immunoglobulins) (where estimated by immunodiffusion, nephelometry, Laurell rocket or similar technique), creatine, hexosamine, lactate, lithium, magnesium, pyruvate, salicylate or xylose—each estimation (SP) | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 |
“1343 | Quantitative estimation of—acid phosphatase, aldolase, amylase, lipase, amylase and lipase, bromide, BSP, caeruloplasmin, carotene, complement fraction, any other specific protein (excluding immunoglobulins) (where estimated by immunodiffusion, nephelometry, Laurell rocket or similar technique), creatine, hexosamine, lactate, lithium, magnesium, pyruvate, salicylate or xylose—each estimation (OP) | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 |
“1345 | Quantitative estimation of—arsenic, copper, gold, lead, mercury, strontium, zinc, folic acid, vitamin B12, alcohol, ammonia, neo-natal bilirubin (direct and indirect), cholinesterase, coproporphyrin, uroporphyrin, any other porphyrin factor, delta ALA, 5HIAA, iron (including iron-binding capacity), oxalate, oxosteroids, oxogenic steroids, PBG, urine oestriol, transketolase or any other substance not specified in any other item in this Division—each estimation (SP) | 19.20 | 19.20 | 19.20 | 19.20 | 19.20 | 19.20 |
|
|
|
| Fees |
|
|
|
Item No. | Medical service | N.S.W. | Vic. | Qld | S.A. | W.A. | Tas. |
|
| $ | $ | $ | $ | $ | $ |
“1346 | Quantitative estimation of—arsenic, copper, gold, lead, mercury, strontium, zinc, folic acid, vitamin B12, alcohol, ammonia, neo-natal bilirubin (direct and indirect), cholinesterase, coproporphyria uroporphyrin, any other porphyrin factor, delta ALA, 5HIAA, iron (including iron-binding capacity), oxalate, oxosteroids, oxogenic steroids, PBG, urine oestriol, transketolase or any substance not specified in any other item in this Division—each estimation (OP) | 14.40 | 14.40 | 14.40 | 14.40 | 14.40 | 14.40 |
“1348 | Dibucaine number or similar, determination of (SP) | 19.20 | 19.20 | 19.20 | 19.20 | 19.20 | 19.20 |
“1349 | Dibucaine number or similar, determination of (OP) | 14.40 | 14.40 | 14.40 | 14.40 | 14.40 | 14.40 |
“1351 | Indican, Qualitative test for (SP)............ | 19.20 | 19.20 | 19.20 | 19.20 | 19.20 | 19.20 |
“1352 | Indican, qualitative test for (OP)............ | 14.40 | 14.40 | 14.40 | 14.40 | 14.40 | 14.40 |
“1354 | Calculus, analysis of (SP)................ | 19.20 | 19.20 | 19.20 | 19.20 | 19.20 | 19.20 |
“1355 | Calculus, analysis of (OP)................ | 14.40 | 14.40 | 14.40 | 14.40 | 14.40 | 14.40 |
“1357 | Amniotic fluid, spectrophotometric analysis of (SP) | 19.20 | 19.20 | 19.20 | 19.20 | 19.20 | 19.20 |
“1358 | Amniotic fluid, sepctrophotometric analysis of (OP) | 14.40 | 14.40 | 14.40 | 14.40 | 14.40 | 14.40 |
“1360 | Electrophoresis, quantitative (including qualitative test) (SP) | 19.20 | 19.20 | 19.20 | 19.20 | 19.20 | 19.20 |
“1362 | Electrophoresis, quantitative (including qualitative test) (OP) | 14.40 | 14.40 | 14.40 | 14.40 | 14.40 | 14.40 |
“1364 | Quantitative estimation of—catecholamines (each component), faecal fat, HMMA, hydroxyproline, blood gases (including pO2, oxygen saturation, pCO2 and estimation of bicarbonate and pH), non-pregnancy oestrogens, pregnanediol, pregnanetriol, any other steroid fraction (where not estimated in the same process as another steroid fraction), or multiple steroid fractions estimated in the same process—each estimation (SP) | 25.50 | 25.50 | 25.50 | 25.50 | 25.50 | 25.50 |
“1366 | Quantitative estimation of— catecholamines (each component), faecal fat, HMMA, hydroxyproline, blood gases (including pO2, oxygen saturation, pCO2 and estimation of bicarbonate and pH), non-pregnancy oestrogens, pregnanediol, pregnanetriol, any other steroid fraction (where not estimated in the same process as another steroid fraction), or multiple steroid fractions estimated in the same process—each estimation (OP) | 19.15 | 19.15 | 19.15 | 19.15 | 19.15 | 19.15 |
“1368 | Chromatography, quantitative estimation (including qualitative test) of any substance not specified in any other item in this Division (SP) | 25.50 | 25.50 | 25.50 | 25.50 | 25.50 | 25.50 |
“1370 | Chromatography, quantitative estimation (including qualitative test) of any substance not specified in any other item in this Division (OP) | 19.15 | 19.15 | 19.15 | 19.15 | 19.15 | 19.15 |
“1372 | Lecithin/sphingomyelin ratio of amniotic fluid, determination of (SP) | 25.50 | 25.50 | 25.50 | 25.50 | 25.50 | 25.50 |
|
|
|
| Fees |
|
|
|
Item No. | Medical service | N.S.W. | Vic. | Qld | S.A. | W.A. | Tas. |
|
| $ | $ | $ | $ | $ | $ |
“1374 | Lecithin/sphingomyelin ratio of amniotic fluid, determination of (OP) | 19.15 | 19.15 | 19.15 | 19.15 | 19.15 | 19.15 |
“1376 | Drug assays—qualitative estimations or screening procedures—one or more estimations or procedures on each specimen (SP) | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 |
“1378 | Drug assays—qualitative estimations or screening procedures—one or more estimations or procedures on each specimen (OP) | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 |
“1380 | Assay by radioimmunoassay, enzyme linked immunoassay, gas liquid chromatography or any other method of barbiturates, carbamazepine, digoxin or phenytoin—estimation of one substance by one or more methods (SP) | 16.00 | 16.00 | 16.00 | 16.00 | 16.00 | 16.00 |
“1381 | Assay by radioimmunoassay, enzyme linked immunoassay, gas liquid chromatography or any other method of barbiturates, carbamazepine, digoxin or phenytoin—estimation of one substance by one or more methods (OP) | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 |
“1382 | Estimation of two substances referred to in item 1380 by using one or more of the methods specified in that item in relation to each (SP) | 25.50 | 25.50 | 25.50 | 25.50 | 25.50 | 25.50 |
“1384 | Estimation of two substances referred to in item 1381 by using one or more of the methods specified in that item in relation to each (OP) | 19.15 | 19.15 | 19.15 | 19.15 | 19.15 | 19.15 |
“1385 | Estimation of three or more substances referred to in item 1380 by using one or more of the methods specified in that item in relation to each (SP) | 32.00 | 32.00 | 32.00 | 32.00 | 32.00 | 32.00 |
“1387 | Estimation of three or more substances referred to in item 1381 by using one or more of the methods specified in that item in relation to each (OP) | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 |
“1392 | Assay by radioimmunoassay, enzyme linked immunoassay, gas liquid chromatography or any other method of diazepam, ethosuximide, methotrexate, morphine, procainamide, quinidine or a similar substance not referred to in any item in this Division other than this item and item 1393— estimation of one substance by one or more methods (SP) | 19.20 | 19.20 | 19.20 | 19.20 | 19.20 | 19.20 |
“1393 | Assay by radioimmunoassay, enzyme linked immunoassay, gas liquid chromatography or any other method of diazepam, ethosuximide, methotrexate, morphine, procainamide, quinidine or a similar substance not referred to in any item in this Division other than this item and item 1392 -estimation of one substance by one or more methods (OP) | 14.40 | 14.40 | 14.40 | 14.40 | 14.40 | 14.40 |
“1394 | Estimation of two substances referred to in item 1392 by using one or more of the methods specified in that item in relation to each (SP) | 32.00 | 32.00 | 32.00 | 32.00 | 32.00 | 32.00 |
|
|
|
| Fees |
|
| |
Item No. | Medical service | N.S.W. | Vic. | Qld | S.A. | W.A. | Tas. |
|
| $ | $ | $ | $ | $ | $ |
“1395 | Estimation of two substances referred to in item 1393 by using one or more of the methods specified in that item in relation to each (OP) | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 |
“1397 | Estimation of three or more substances referred to in item 1392 by using one or more of the methods specified in that item in relation to each (SP) | 38.50 | 38.50 | 38.50 | 38.50 | 38.50 | 38.50 |
“1398 | Estimation of three or more substances referred to in item 1393 by using one or more of the methods specified in that item in relation to each (OP) | 28.90 | 28.90 | 28.90 | 28.90 | 28.90 | 28.90 |
“Hormone Assays not covered by any other item in this Division | |||||||
“1419 | Assay of thryoxine (T4) or T3 resin uptake (or equivalent function test)— using any technique (SP) | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 |
“1420 | Assay of thyroxine (T4) or T3 resin uptake (or equivalent function test)— using any technique (OP) | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 |
“1427 | Assay of thyroxine (T4) and T3 resin uptake (or equivalent function test)— using any technique (SP) | 16.00 | 16.00 | 16.00 | 16.00 | 16.00 | 16.00 |
“1428 | Assay of thyroxine (T4) and T3 resin uptake (or equivalent function test)— using any technique (OP) | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 |
“1434 | Assay of normalised thyroxine (effective thyroxine ratio) or similar assay—when not associated with a procedure to which item 1419 or 1427 applies— assay using any technique (SP) | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 |
“1435 | Assay of normalised thyroxine (effective thyroxine ratio) or similar assay—when not associated with a procedure to which item 1420 or 1428 applies— assay using any technique (OP) | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 |
“1441 | Assay of thyroxine (T4), T3 resin uptake (or equivalent function test) and normalised thyroxine (effective thyroxine ratio) or similar assay performed by a different procedure—assay using any technique (SP) | 22.50 | 22.50 | 22.50 | 22.50 | 22.50 | 22.50 |
“1442 | Assay of thyroxine (T4), T3 resin uptake (or equivalent function test) and normalised thyroxine (effective thyroxine ratio) or similar assay performed by a different procedure—assay using any technique (OP) | 16.90 | 16.90 | 16.90 | 16.90 | 16.90 | 16.90 |
“1452 | Hormone assays using gamma emitting labels or any other unspecified technique (excluding thyroid hormones covered by items 1419, 1427, 1434 and 1441)—one estimation of any one hormone (SP) | 19.20 | 19.20 | 19.20 | 19.20 | 19.20 | 19.20 |
“1453 | Hormone assays using gamma emitting labels or any other unspecified technique (excluding thyroid hormones covered by items 1420, 1428, 1435 and 1442)—one estimation of any one hormone (OP) | 14.40 | 14.40 | 14.40 | 14.40 | 14.40 | 14.40 |
“1455 | 2 estimations of any one hormone using any technique referred to in item 1452 (SP) | 29.00 | 29.00 | 29.00 | 29.00 | 29.00 | 29.00 |
|
|
|
| Fees |
|
| |
Item No. | Medical service | N.S.W. | Vic. | Qld | S.A. | W.A. | Tas. |
|
| $ | $ | $ | $ | $ | $ |
“1456 | 2 estimations of any one hormone using any technique referred to in item 1453 (OP) | 21.75 | 21.75 | 21.75 | 21.75 | 21.75 | 21.75 |
“1458 | 3 estimations of any one hormone using any technique referred to in item 1452 (SP) | 38.50 | 38.50 | 38.50 | 38.50 | 38.50 | 38.50 |
“1459 | 3 estimations of any one hormone using any technique referred to in item 1453 (OP) | 28.90 | 28.90 | 28.90 | 28.90 | 28.90 | 28.90 |
“1461 | Each estimation of any one hormone in excess of three estimations using any technique referred to in item 1452 (SP) | 3.90 | 3.90 | 3.90 | 3.90 | 3.90 | 3.90 |
“1462 | Each estimation of any one hormone in excess of three estimations using any technique referred to in item 1453 (OP) | 2.95 | 2.95 | 2.95 | 2.95 | 2.95 | 2.95 |
“1475 | Hormone assay using beta emitting labels or bioassay techniques—one estimation of any one hormone (SP) | 32.00 | 32.00 | 32.00 | 32.00 | 32.00 | 32.00 |
“1476 | Hormone assay using beta emitting labels or bioassay techniques—one estimation of any one hormone (OP) | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 |
“1478 | Hormone assays using beta emitting labels or bioassay techniques—two estimations of any one hormone (SP) | 51.00 | 51.00 | 51.00 | 51.00 | 51.00 | 51.00 |
“1479 | Hormone assays using beta emitting labels or bioassay techniques—two estimations of any one hormone (OP) | 38.25 | 38.25 | 38.25 | 38.25 | 38.25 | 38.25 |
“1481 | Hormone assays using beta emitting labels or bioassay techniques—three estimations of any one hormone (SP) | 64.00 | 64.00 | 64.00 | 64.00 | 64.00 | 64.00 |
“1482 | Hormone assays using beta emitting labels or bioassay techniques—three estimations of any one hormone (OP) | 48.00 | 48.00 | 48.00 | 48.00 | 48.00 | 48.00 |
“1484 | Hormone assays using beta emitting labels or bioassay techniques—each estimation of any one hormone in excess of three (SP) | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 |
“1485 | Hormone assays using beta emitting labels or bioassay techniques—each estimation of any one hormone in excess of three (OP) | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 |
“Procedural Services | |||||||
“1504 | Procedural services associated with— ACTH stimulation test, adrenaline tolerance test, arginine infusion test, bromsulphthalein test, carbohydrate tolerance test, creatinine clearance test, gastric function test requiring intubation, glucagon tolerance test, histidine loaded FIGLU test, 1-dopa stimulation test, phenolsulphthalein excretion test, TSH stimulation test (other than the administration of TSH), urea clearance test, urea concentration test, vasopressin stimulation test, xylose absorption test, or any similar test (SP) | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 |
|
|
|
| Fees |
|
|
|
Item No. | Medical service | N.S.W. | Vic. | Qld | S.A. | W.A. | Tas. |
|
| $ | $ | $ | $ | $ | $ |
“1505 | Procedural services associated with— ACTH stimulation test, adrenaline tolerance test, arginine infusion test, bromsulphthalein test, carbohydrate tolerance test, creatinine clearance test, gastric function test requiring intubation, glucagon tolerance test, histidine loaded FIGLU test, 1-dopa stimulation test, phenolsulphthalein excretion test, TSH stimulation test (other than the administration of TSH), urea clearance test, urea concentration test, vasopressin stimulation test, xylose absorption test, or any similar test (OP) | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 |
“1511 | Procedural services associated with— tolbutamide test, insulin hypoglycaemia stimulation test, gonadotrophin releasing hormone stimulation test (other than the administration of gonadotrophin releasing hormone), thyrotrophin releasing hormone stimulation test (other than the administration of thyroid stimulating hormone), urine acidification test, or any similar test (SP) | 19.20 | 19.20 | 19.20 | 19.20 | 19.20 | 19.20 |
“1512 | Procedural services associated with— tolbutamide test, insulin hypoglycaemia stimulation test, gonadotrophin releasing hormone stimulation test (other than the administration of gonadotrophin releasing hormone), thyrotrophin releasing hormone stimulation test (other than the administration of thyroid stimulating hormone), urine acidification, test, or any similar test (OP) | 14.40 | 14.40 | 14.40 | 14.40 | 14.40 | 14.40 |
“11516 | Procedural services associated with the administration of—thyrotrophin releasing hormone, gonadotrophin releasing hormone or thyroid stimulating hormone (SP) | 16.00 | 16.00 | 16.00 | 16.00 | 16.00 | 16.00 |
“1517 | Procedural services associated with the administration of—thyrotrophin releasing hormone, gonadotrophin releasing hormone or thyroid stimulating hormone (OP) | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 |
““Division 3—Microbiology | |||||||
“1529 | Microscopical examination, wet film, not covered by item 1536 (SP) | 3.90 | 3.90 | 3.90 | 3.90 | 3.90 | 3.90 |
“1530 | Microscopical examination, wet film, not covered by item 1537 (OP) | 2.95 | 2.95 | 2.95 | 2.95 | 2.95 | 2.95 |
“1536 | Microscopical examination of urine and examination for one or more of pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone and bile pigments (SP) | 5.10 | 5.10 | 5.10 | 5.10 | 5.10 | 5.10 |
“1537 | Microscopical examination of urine and examination for one or more of pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone and bile pigments (where the patient is referred by another medical practitioner) (OP) | 3.85 | 3.85 | 3.85 | 3.85 | 3.85 | 3.85 |
|
|
|
| Fees |
|
|
|
Item No. | Medical service | N.S.W. | Vic. | Qld | S.A. | W.A. | Tas. |
|
| $ | $ | $ | $ | $ | $ |
“1545 | Microscopical examination using gram or similar stain (e.g. Loeffler, methylene blue, Giemsa)—one stain (SP) | 5.10 | 5.10 | 5.10 | 5.10 | 5.10 | 5.10 |
“1546 | Microscopical examination using gram or similar stain (e.g. Loeffler, methylene blue, Giemsa) —one stain (OP) | 3.85 | 3.85 | 3.85 | 3.85 | 3.85 | 3.85 |
“1548 | Microscopical examination using gram or similar stain (e.g. Loeffler, methylene blue, Giemsa)—two or more stains (SP) | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 |
“1549 | Microscopical examination using gram or similar stain (e.g. Loeffler, methylene blue, Giemsa)—two or more stains (OP) | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 |
“1556 | Microscopical examination using special stain (e.g. Ziehl-Neelsen or similar stain)—one stain (SP) | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 |
“1557 | Microscopical examination using special stain (e.g. Ziehl-Neelsen or similar stain)—one stain (OP) | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 |
“1566 | Microscopical examination using 2 or more stains, one or more of which is a special stain referred to in item 1556 (SP) | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 |
“1567 | Microscopical examination using 2 or more stains, one or more of which is a special stain referred to in item 1557 (OP) | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 |
“1586 | Microscopical examination for dermatophytes—examination of material from one site (SP) | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 |
“1587 | Microscopical examination for dermatophytes—examination of material from one site (OP) | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 |
“1588 | Microscopical examination for dermatophytes—examination of material from 2 or more sites (SP) | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 |
“1589 | Microscopical examination for dermatophytes—examination of material from 2 or more sites (OP) | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 |
“1604 | Microscopical examination of exudate by dark ground illumination for Treponema pallidum (SP) | 16.00 | 16.00 | 16.00 | 16.00 | 16.00 | 16.00 |
“1606 | Microscopical examination of exudate by dark ground illumination for Treponema pallidum (OP) | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 |
“1609 | Cultural examination of a specimen other than urine for aerobic micro-organisms (including fungi) with, where indicated, the use of relevant stains, selective media or sensitivity testing or any 2 or more of those procedures (SP) | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 |
“1610 | Cultural examination of a specimen other than urine for aerobic micro-organisms (including fungi) with, where indicated, the use of relevant stains, selective media or sensitivity testing or any 2 or more of those procedures (OP) | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 |
|
|
|
| Fees |
|
|
|
Item No. | Medical service | N.S.W. | Vic. | Qld | S.A. | W.A. | Tas. |
|
| $ | $ | $ | $ | $ | $ |
“1611 | Cultural examination of a specimen other than urine for aerobic micro-organisms (including fungi) with, where indicated, the use of relevant stains, selective media or sensitivity testing or any 2 or more of those procedures (HP) | 8.10 | 8.10 | 8.10 | 8.10 | 8.10 | 8.10 |
“1615 | Cultural examination of a specimen other then blood or urine for aerobic and anaerobic micro-organisms using an anaerobic atmosphere for the culture of anaerobes, with, where indicated, the use of relevant stains, selective media or sensitivity testing or any 2 or more of those procedures (SP) | 19.20 | 19.20 | 19.20 | 19.20 | 19.20 | 19.20 |
“1616 | Cultural examination of a specimen other than blood or urine for aerobic and anaerobic micro-organisms using an anaerobic atmosphere for the culture of anaerobes, with, where indicated, the use of relevant stains, selective media or sensitivity testing or any 2 or more of those procedures (OP) | 14.40 | 14.40 | 14.40 | 14.40 | 14.40 | 14.40 |
“1618 | Cultural examination of a specimen other than blood or urine for aerobic and anaerobic micro-organisms, using an anaerobic atmosphere for the culture of anaerobes, with, where indicated, the use of relevant stains, selective media or sensitivity testing or any 2 or more of those procedures (HP) | 12.10 | 12.10 | 12.10 | 12.10 | 12.10 | 12.10 |
“1622 | Cultural examination for mycobacteria— each specimen (SP) | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 |
“1623 | Cultural examination for mycobacteria— each specimen (OP) | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 |
“1633 | Blood culture, including sub-culture, using both aerobic and anaerobic media, with, where indicated, the use of relevant stains or sensitivity testing or relevant stains and sensitivity testing, but not involving organism identification—each set of cultures to a maximum of 3 sets (SP) | 19.20 | 19.20 | 19.20 | 19.20 | 19.20 | 19.20 |
“1634 | Blood culture, including sub-culture, using both aerobic and anaerobic media, with, where indicated, the use of relevant stains or sensitivity testing or relevant stains and sensitivity testing, but not involving organism identification—each set of cultures to a maximum of three sets (OP) | 14.40 | 14.40 | 14.40 | 14.40 | 14.40 | 14.40 |
“1636 | Blood culture, including sub-culture, using both aerobic and anaerobic media, with, where indicated, the use of relevant stains or sensitivity testing or relevant stains and sensitivity testing, but not involving organism identification—each set of cultures to a maximum of three sets (HP) | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 |
|
|
|
| Fees |
|
|
|
Item No. | Medical service | N.S.W. | Vic. | Qld | S.A. | W.A. | Tas. |
|
| $ | $ | $ | $ | $ | $ |
“1644 | Identification of pathogenic microorganisms using biochemical tests or other special techniques involving subculture or biochemical tests and other special techniques involving subculture—identification of one organism (SP) | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 |
“1645 | Identification of pathogenic microorganisms using biochemical tests or other special techniques involving subculture or biochemical tests and other special techniques involving subculture—identification of one organism (OP) | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 |
“1647 | Identification of two or more organisms by the method referred to in item 1644 (SP) | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 |
“1648 | Identification of two or more organisms by the method referred to in item 1645 (OP) | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 |
“1661 | Identification of pathogenic microorganisms using a serological technique (including the immunofluorescent or immunoenzymic methods)—a procedure involving one technique (SP) | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 |
“1662 | Identification of pathogenic microorganisms using a serological technique (including the immunofluorescent or immunoenzymic methods)—a procedure involving one technique (OP) | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 |
“1664 | 2 or more of any procedures of a kind referred to in item 1661 using different techniques (SP) | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 |
“1665 | 2 or more of any procedures of a kind referred to in item 1662 using different techniques (OP) | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 |
“1673 | Microscopical examination of urine, with cell count, relevant stains (if indicated), cultural examination and colony count of micro-organisms (not being a service to which item 1682 applies), together with sensitivity testing (where indicated) and general examination for one or more of pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone and bile pigments (SP) | 18.00 | 18.00 | 18.00 | 18.00 | 18.00 | 18.00 |
“1674 | Microscopical examination of urine, with cell count, relevant stains (if indicated), cultural examination and colony count of micro-organisms (not being a service to which item 1683 applies), with sensitivity testing (where indicated) and general examination for one or more of pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone and bile pigments (OP) | 13.50 | 13.50 | 13.50 | 13.50 | 13.50 | 13.50 |
|
|
|
| Fees |
|
| |
Item No. | Medical service | N.S.W. | Vic. | Qld | S.A. | W.A. | Tas. |
|
| $ | $ | $ | $ | $ | $ |
“1676 | Microscopical examination of urine, with cell count, relevant stains (if indicated), cultural examination and colony count of micro-organisms (not being a service to which item 1682 or 1683 applies) with sensitivity testing (where indicated) and general examination for one or more of pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone and bile pigments (HP) | 9.00 | 9.00 | 9.00 | 9.00 | 9.00 | 9.00 |
“1682 | Microscopical examination of urine and simple culture by means of dip slide or microbiological kit test (SP) | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 |
“1683 | Microscopical examination of urine and simple culture by means of dip slide or microbiological kit test (where the patient is referred by another medical practitioner) (OP) | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 |
“1687 | Microscopical examination of faeces or body fluids for parasites, cysts or ova, with or without simple stains or concentration techniques (SP) | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 |
“1688 | Microscopical examination of faeces or body fluids for parasites, cysts or ova, with or without simple stains or concentration techniques (OP) | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 |
“1693 | Identification of helminths (SP).......... | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 |
“1694 | Identification of helminths (OP)......... | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 |
“1702 | Cultural examination for parasites, other than trichomonas—culture of one parasite (SP) | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 |
“1703 | Cultural examination for parasites, other than trichomonas—culture of one parasite (OP) | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 |
“1705 | Cultural examination for parasites, other than trichomonas—culture of 2 or more parasites (SP) | 22.50 | 22.50 | 22.50 | 22.50 | 22.50 | 22.50 |
“1706 | Cultural examination for parasites, other than trichomonas—culture of two or more parasites (OP) | 16.90 | 16.90 | 16.90 | 16.90 | 16.90 | 16.90 |
“1712 | Examination by animal innoculation (SP)... | 25.50 | 25.50 | 25.50 | 25.50 | 25.50 | 25.50 |
“1713 | Examination by animal innoculation (OP)... | 19.15 | 19.15 | 19.15 | 19.15 | 19.15 | 19.15 |
“1721 | Determination of the minimum inhibitory concentration of an antibiotic or chemotherapeutic agent by tube technique—one organism (SP) | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 |
“1722 | Determination of the minimum inhibitory concentration of an antibiotic or chemotherapeutic agent by tube technique—one organism (OP) | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 |
“1724 | Determination of the minimum inhibitory concentration of an antibiotic or chemotherapeutic agent by tube technique—two or more organisms (SP) | 16.00 | 16.00 | 16.00 | 16.00 | 16.00 | 16.00 |
“1725 | Determination of the minimum inhibitory concentration of an antibiotic or chemotherapeutic agent by tube technique-two or more organisms (OP) | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 |
|
|
|
| Fees |
|
|
|
Item No. | Medical service | N.S.W. | Vic. | Qld | S.A. | W.A. | Tas. |
|
| $ | $ | $ | $ | $ | $ |
“1732 | Detection of substances inhibitory to micro-organisms in a body fluid (including urine) (SP) | 3.20 | 3.20 | 3.20 | 3.20 | 3.20 | 3.20 |
“1733 | Detection of substances inhibitory to micro-organisms in a body fluid (including urine) (OP) | 2.40 | 2.40 | 2.40 | 2.40 | 2.40 | 2.40 |
“1743 | Quantitative assay of an antibiotic or a chemotherapeutic agent in a body fluid (including urine) (SP) | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 |
“1744 | Quantitative assay of an antibiotic or a chemotherapeutic agent in a body fluid (including urine) (OP) | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 |
“1760 | Agglutination tests (quantitative), including those for enteric fever and brucellosis—one antigen (SP) | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 |
“1761 | Agglutination tests (quantitative), including those for enteric fever and brucellosis—one antigen (OP) | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 |
“1763 | Agglutination tests (quantitative), including those for enteric fever and brucellosis—second to sixth antigen-each antigen (SP) | 5.10 | 5.10 | 5.10 | 5.10 | 5.10 | 5.10 |
“1764 | Agglutination tests (quantitative), including those for enteric fever and brucellosis—second to sixth antigen-each antigen (OP) | 3.85 | 3.85 | 3.85 | 3.85 | 3.85 | 3.85 |
“1766 | Agglutination tests (quantitative), including those for enteric fever and brucellosis—each antigen in excess of six (SP) | 2.60 | 2.60 | 2.60 | 2.60 | 2.60 | 2.60 |
“1767 | Agglutination tests (quantitative), including those for enteric fever and brucellosis—each antigen in excess of six (OP) | 1.95 | 1.95 | 1.95 | 1.95 | 1.95 | 1.95 |
“1772 | Flocculation test, including V.D.R.L., Kahn, Kline or similar tests—one test (SP) | 3.20 | 3.20 | 3.20 | 3.20 | 3.20 | 3.20 |
“1773 | Flocculation test, including V.D.R.L., Kahn, Kline or similar tests—one test (OP) | 2.40 | 2.40 | 2.40 | 2.40 | 2.40 | 2.40 |
“1775 | Flocculation tests, including V.D.R.L., Kahn, Kline or similar tests—two or more tests (SP) | 3.90 | 3.90 | 3.90 | 3.90 | 3.90 | 3.90 |
“1776 | Flocculation tests, including V.D.R.L., Kahn, Kline or similar tests—two or more tests (OP) | 2.95 | 2.95 | 2.95 | 2.95 | 2.95 | 2.95 |
“1781 | Complement fixation tests—one test (SP).... | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 |
“1782 | Complement fixation tests—one test (OP).... | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 |
“1784 | Complement fixation tests—each test in excess of one (SP) | 3.20 | 3.20 | 3.20 | 3.20 | 3.20 | 3.20 |
“1785 | Complement fixation tests—each test in excess of one (OP) | 2.40 | 2.40 | 2.40 | 2.40 | 2.40 | 2.40 |
“1793 | Fluorescent serum antibody test (FTA test, FTA—absorbed test or similar)— one test (SP) | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 |
“1794 | Fluorescent serum antibody test (FTA test, FTA—absorbed test or similar)— one test (OP) | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 |
“1796 | Each test referred to in item 1793 in excess of one (SP) | 5.10 | 5.10 | 5.10 | 5.10 | 5.10 | 5.10 |
“1797 | Each test referred to in item 1794 in excess of one (OP) | 3.85 | 3.85 | 3.85 | 3.85 | 3.85 | 3.85 |
“1805 | Haemagglutination tests—one test (SP)...... | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 |
“1806 | Haemagglutination tests—one test (OP)..... | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 |
|
|
|
| Fees |
|
| |
Item No. | Medical service | N.S.W. | Vic. | Qld | S.A. | W.A. | Tas. |
|
| $ | $ | $ | $ | $ | $ |
“1808 | Haemagglutination tests—each test in excess of one (SP) | 3.20 | 3.20 | 3.20 | 3.20 | 3.20 | 3.20 |
“1809 | Haemagglutination tests—each test in excess of one (OP) | 2.40 | 2.40 | 2.40 | 2.40 | 2.40 | 2.40 |
“1823 | Haemagglutination inhibition tests—one test (SP) | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 |
“1824 | Haemagglutination inhibition tests—one test (OP) | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 |
“1826 | Haemagglutination inhibition tests—each test in excess of one (SP) | 3.20 | 3.20 | 3.20 | 3.20 | 3.20 | 3.20 |
“1827 | Haemagglutination inhibition tests—each test in excess of one (OP) | 2.40 | 2.40 | 2.40 | 2.40 | 2.40 | 2.40 |
“1843 | Antistreptolysin O titre test (SP)......... | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 |
“1844 | Antistreptolysin O titre test (OP)......... | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 |
“1851 | Total and differential cell count on any body fluid other than urine (SP) | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 |
“1852 | Total and differential cell count on any body fluid other than urine (OP) | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 |
“1858 | Autogenous vaccine, preparation of— each organism (SP) | 25.50 | 25.50 | 25.50 | 25.50 | 25.50 | 25.50 |
“1859 | Autogenous vaccine, preparation of— each organism (OP) | 19.15 | 19.15 | 19.15 | 19.15 | 19.15 | 19.15 |
“Division 4—Immunology | |||||||
“1877 | Immunoelectrophoresis using polyvalent antisera (SP) | 19.20 | 19.20 | 19.20 | 19.20 | 19.20 | 19.20 |
“1878 | Immunoelectrophoresis using polyvalent antisera (OP) | 14.40 | 14.40 | 14.40 | 14.40 | 14.40 | 14.40 |
“1884 | Immunoelectrophoresis using monovalent antiserum—each antiserum (SP) | 3.20 | 3.20 | 3.20 | 3.20 | 3.20 | 3.20 |
“1885 | Immunoelectrophoresis using monovalent antiserum—each antiserum (OP) | 2.40 | 2.40 | 2.40 | 2.40 | 2.40 | 2.40 |
“1888 | Immunoglobulins G, A, M or D, quantitative estimation of by immunodiffusion or any other method —estimation of one immunoglobulin (SP) | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 |
“1889 | Immunoglobulins G, A, M or D, quantitative estimation of by immunodiffusion or any other method —estimation of one immunoglobulin (OP) | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 |
“1891 | Immunoglobulins G, A, M or D, quantitative estimation of by immunodiffusion or any other method —estimation of each immunoglobulin in excess of one (SP) | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 |
“1892 | Immunoglobulins, G, A, M or D, quantitative estimation of by immunodiffusion or any other method —estimation of each immunoglobulin in excess of one (OP) | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 |
“1897 | Immunoglobulin E, quantitative estimation of (SP) | 19.20 | 19.20 | 19.20 | 19.20 | 19.20 | 19.20 |
“1898 | Immunoglobulin E, quantitative estimation of (OP) | 14.40 | 14.40 | 14.40 | 14.40 | 14.40 | 14.40 |
“1903 | Radioallergosorbent tests for allergen identification—identification of one to four allergens—each allergen (SP) | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 |
“1904 | Radioallergosorbent tests for allergen identification—identification of one to four allergens—each allergen (OP) | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 |
|
|
|
| Fees |
|
|
|
Item No. | Medical service | N.S.W. | Vic. | Qld | S.A. | W.A. | Tas. |
|
| $ | $ | $ | $ | $ | $ |
“1905 | Radioallergosorbent tests for allergen identification—identification of each allergen in excess of four (SP) | 3.20 | 3.20 | 3.20 | 3.20 | 3.20 | 3.20 |
“1906 | Radioallergosorbent tests for allergen identification—identification of each allergen in excess of four (OP) | 2.40 | 2.40 | 2.40 | 2.40 | 2.40 | 2.40 |
“1911 | Immunofluorescent detection of tissue antibodies, qualitative (not associated with the service specified in item 1918), detection of one antibody (SP) | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 |
“1912 | Immunofluorescent detection of tissue antibodies, qualitative (not associated with the service specified in item 1919), detection of one antibody (OP) | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 |
“1913 | Immunofluorescent detection of tissue antibodies, qualitative (not associated with the service specified in item 1918), detection of each antibody in excess of one (SP) | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 |
“1914 | Immunofluorescent detection of tissue antibodies, qualitative (not associated with the service specified in item 1919), detection of each antibody in excess of one (OP) | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 |
“1918 | Immunofluorescent detection of tissue antibodies, qualitative and quantitative—detection and estimation of each antibody (SP) | 16.00 | 16.00 | 16.00 | 16.00 | 16.00 | 16.00 |
“1919 | Immunofluorescent detection of tissue antibodies, qualitative and quantitative—detection and examination of each antibody (OP) | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 |
“1924 | Complement fixation tests on human tissue antibodies—one antibody (SP) | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 |
“1925 | Complement fixation tests on human tissue antibodies—one antibody (OP) | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 |
“1926 | Complement fixation tests on human tissue antibodies—each antibody in excess of one (SP) | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 |
“1927 | Complement fixation tests on human tissue antibodies—each antibody in excess of one (OP) | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 |
“1935 | Latex flocculation test—qualitative, quantitative or qualitative and quantitative (SP) | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 |
“1936 | Latex flocculation test—qualitative, quantitative or qualitative and quantitative (OP) | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 |
“1941 | Rose Waaler test, quantitative, using sheep cells (SP) | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 |
“1942 | Rose Waaler test, quantitative, using sheep cells (OP) | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 |
“1948 | Lupus erythematosus cells, preparation and examination of film for (SP) | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 |
“1949 | Lupus erythematosus cells, preparation and examination of film for (OP) | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 |
“1955 | Tanned erythrocyte haemagglutination test for tissue antibodies—one antibody (SP) | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 |
“1956 | Tanned erythrocyte haemagglutination test for tissue antibodies—one antibody (OP) | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 |
|
|
|
| Fees |
|
|
|
Item No. | Medical service | N.S.W. | Vic. | Qld | S.A. | W.A. | Tas. |
|
| $ | $ | $ | $ | $ | $ |
“1957 | Tanned erythrocyte haemagglutination test for tissue antibodies—each antibody in excess of one (SP) | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 |
“1958 | Tanned erythrocyte haemagglutination test for tissue antibodies—each antibody in excess of one (OP) | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 |
“1965 | Leucocyte fractionation as preliminary test to specific tests of leucocyte function by density gradient centrifugation or any other method (SP) | 19.20 | 19.20 | 19.20 | 19.20 | 19.20 | 19.20 |
“1966 | Leucocyte fractionation as preliminary test to specific tests of leucocyte function by density gradient centrifugation or any other method (OP) | 14.40 | 14.40 | 14.40 | 14.40 | 14.40 | 14.40 |
“1971 | Neutrophil function tests for phagocytic activity—visual techniques (SP) | 19.20 | 19.20 | 19.20 | 19.20 | 19.20 | 19.20 |
“1972 | Neutrophil function tests for phagocytic activity—visual techniques (OP) | 14.40 | 14.40 | 14.40 | 14.40 | 14.40 | 14.40 |
“1973 | Neutrophil function tests for phagocytic activity—radioactive techniques (SP) | 32.00 | 32.00 | 32.00 | 32.00 | 32.00 | 32.00 |
“1974 | Neutrophil function tests for phagocytic activity—radioactive techniques (OP) | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 |
“1981 | Lymphocyte cell count—E. rosette technique or similar (SP) | 25.50 | 25.50 | 25.50 | 25.50 | 25.50 | 25.50 |
“1982 | Lymphocyte cell count—E. rosette tech-nique or similar (OP) | 19.15 | 19.15 | 19.15 | 19.15 | 19.15 | 19.15 |
“1987 | B lymphocyte cell count—by immunofluorescence or immuno-peroxidase (SP) | 25.50 | 25.50 | 25.50 | 25.50 | 25.50 | 25.50 |
“1988 | B lymphocyte cell count —by immunofluorescence or immuno-peroxidase (OP) | 19.15 | 19.15 | 19.15 | 19.15 | 19.15 | 19.15 |
“1995 | Lymphocyte function test—visual transformation (SP) | 25.50 | 25.50 | 25.50 | 25.50 | 25.50 | 25.50 |
“1996 | Lymphocyte function test—visual transformation (OP) | 19.15 | 19.15 | 19.15 | 19.15 | 19.15 | 19.15 |
“1997 | Lymphocyte function test—radioactive techniques (SP) | 38.50 | 38.50 | 38.50 | 38.50 | 38.50 | 38.50 |
“1998 | Lymphocyte function text — radioactive techniques (OP) | 28.90 | 28.90 | 28.90 | 28.90 | 28.90 | 28.90 |
“2006 | Tissue group typing (HLA phenotyping) (SP). | 32.00 | 32.00 | 32.00 | 32.00 | 32.00 | 32.00 |
“2007 | Tissue group typing (HLA phenotyping) (OP) | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 |
“2013 | Skin sensitivity testing (Mantoux, Schick, Casoni or similar test)—each test (SP) | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 |
“2014 | Skin sensitivity testing (Mantoux, Schick, Casoni or similar test)—each test (OP) | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 |
“2022 | Skin sensitivity—induction and detection of sensitivity to chemical antigens (SP) | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 |
“2023 | Skin sensitivity—induction and detection of sensitivity to chemical antigens (OP) | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 |
“Division 5—Histopathology | |||||||
“2041 | Histopathology examination of biopsy material—processing of one or more paraffin blocks, with all appropriate stains and provision of professional opinion (SP) | 45.00 | 45.00 | 45.00 | 45.00 | 45.00 | 45.00 |
“2042 | Histopathology examination of biopsy material—processing of one or more paraffin blocks, with all appropriate stains and provision of professional opinion (OP) | 33.75 | 33.75 | 33.75 | 33.75 | 33.75 | 33.75 |
|
|
|
| Fees |
|
|
| |
Item No. | Medical service | N.S.W. | Vic. | Qld | S.A. | W.A. | Tas. | |
|
| $ | $ | $ | $ | $ | $ | |
“2048 | Immediate frozen section diagnosis of biopsy material performed at the pathologist’s laboratory and confirmatory histopathology examination of this material after the frozen section using all appropriate stains (SP) | 58.00 | 58.00 | 58.00 | 58.00 | 58.00 | 58.00 | |
“2049 | Immediate frozen section diagnosis of biopsy material performed at the pathologist’s laboratory and confirmatory histopathology examination of this material after the frozen section using all appropriate stains (OP) | 43.50 | 43.50 | 43.50 | 43.50 | 43.50 | 43.50 | |
“2056 | Immediate frozen section diagnosis of biopsy material performed at a distance of one or more kilometres from the pathologist’s laboratory and confirmatory histopathology examination of this material after the frozen section using all appropriate stains (SP) | 83.00 | 83.00 | 83.00 | 83.00 | 83.00 | 83.00 | |
“2057 | Immediate frozen section diagnosis of biopsy material performed at a distance of one or more kilometres from the pathologist’s laboratory and confirmatory histopathology examination of this material after the frozen section using all appropriate stains (OP) | 62.25 | 62.25 | 62.25 | 62.25 | 62.25 | 62.25 | |
“Division 6—Cytology | ||||||||
“2081 | Cytological examination for pathological change of smears from cervix and vagina, skin or mucous membrane—each examination (SP) | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 | |
“2082 | Cytological examination for pathological change of smears from cervix and vagina, skin or mucous membrane—each examination (OP) | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 | |
“2091 | Cytological examination for malignant cells—examination of sputum, urine, bronchial secretion, cerebrospinal fluid, peritoneal fluid or any similar fluid—each examination (SP) | 19.20 | 19.20 | 19.20 | 19.20 | 19.20 | 19.20 | |
“2092 | Cytological examination for malignant cells—examination of sputum, urine, bronchial secretion, cerebrospinal fluid, peritoneal fluid or any similar fluid—each examination (OP) | 14.40 | 14.40 | 14.40 | 14.40 | 14.40 | 14.40 | |
“2096 | Cytological examination for malignant cells—examination of gastric washings, duodenal washings, oesophageal washings or colonic washings—each examination (SP) | 25.50 | 25.50 | 25.50 | 25.50 | 25.50 | 25.50 | |
“2097 | Cytological examination for malignant cells—examination of gastric washings, duodenal washings, oesophageal washings or colonic washings—each examination (OP) | 19.15 | 19.15 | 19.15 | 19.15 | 19.15 | 19.15 | |
“2104 | Hormonal assessment by cytological examination of vaginal epithelium involving cell count, index or both (SP) | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 | |
“2105 | Hormonal assessment by cytological examination of vaginal epithelium involving cell count, index or both (OP) | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 | |
|
|
|
| Fees |
|
|
|
Item No. | Medical service | N.S.W. | Vic. | Qld | S.A. | W.A. | Tas. |
|
| $ | $ | $ | $ | $ | $ |
“2111 | Cytological examination for pathological change of smears from cervix and vagina with hormonal assessment by cytological examination of vaginal epithelium involving cell count, index or both (SP) | 16.00 | 16.00 | 16.00 | 16.00 | 16.00 | 16.00 |
“2112 | Cytological examination for pathological change of smears from cervix and vagina with hormonal assessment by cytological examination of vaginal epithelium involving cell count, index or both (OP) | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 |
“Division 7—Cytogenetics | |||||||
“2131 | Cytological sex determination from blood film (SP) | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 |
“2132 | Cytological sex determination from blood film (OP) | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 |
“2141 | Cytological sex chromatin studies (Barr or Y bodies)—other than from blood film—each tissue examined (SP) | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 |
“2142 | Cytological sex chromatin studies (Barr or Y bodies)—other than from blood film—each tissue examined (OP) | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 |
“2148 | Chromosome studies, including preparation, count and karyotyping of omniotic fluid (SP) | 96.00 | 96.00 | 96.00 | 96.00 | 96.00 | 96.00 |
“2149 | Chromosome studies, including preparation, count and karyotyping of amniotic fluid (OP) | 72.00 | 72.00 | 72.00 | 72.00 | 72.00 | 72.00 |
“2155 | Chromosome studies, including preparation, count and karyotyping of bone marrow (SP) | 64.00 | 64.00 | 64.00 | 64.00 | 64.00 | 64.00 |
“2156 | Chromosome studies, including preparation, count and karyotyping of bone marrow (OP) | 48.00 | 48.00 | 48.00 | 48.00 | 48.00 | 48.00 |
“2161 | Chromosome studies, including preparation, count and karyotyping of blood, skin or any tissue or fluid not referred to in item 2148 or 2155—each study (SP) | 77.00 | 77.00 | 77.00 | 77.00 | 77.00 | 77.00 |
“2162 | Chromosome studies, including preparation, count and karyotyping of blood, skin or any tissue or fluid not referred to in item 2149 or 2156-each study (OP) | 57.75 | 57.75 | 57.75 | 57.75 | 57.75 | 57.75 |
“2170 | Chromosome identification by banding techniques (using fluorescein, Giemsa or centromeres staining)—one method (SP) | 64.00 | 64.00 | 64.00 | 64.00 | 64.00 | 64.00 |
“2171 | Chromosome identification by banding techniques (using fluorescein, Giemsa or centromeres staining)—one method (OP) | 48.00 | 48.00 | 48.00 | 48.00 | 48.00 | 48.00 |
“2173 | Chromosome identification by banding techniques (using fluorescein, Giemsa or centromeres staining)—two or more methods (SP) | 96.00 | 96.00 | 96.00 | 96.00 | 96.00 | 96.00 |
“2174 | Chromosome identification by banding techniques (using fluorescein, Giemsa or centromeres staining)—two or more methods (OP) | 72.00 | 72.00 | 72.00 | 72.00 | 72.00 | 72.00 |
|
|
|
| Fees |
|
|
|
Item No. | Medical service | N.S.W. | Vic. | Qld | S.A. | W.A. | Tas. |
|
| $ | $ | $ | $ | $ | $ |
Division 8—Infertility and Pregnancy Tests | |||||||
“2201 | Examination of semen for presence of spermatozoa (SP) | 3.90 | 3.90 | 3.90 | 3.90 | 3.90 | 3.90 |
“2202 | Examination of semen for presence of spermatozoa (OP) | 2.95 | 2.95 | 2.95 | 2.95 | 2.95 | 2.95 |
“2211 | Huhner’s test (post-coital test) — collection of sample and examination of wet preparation (SP) | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 |
“2212 | Huhner’s test (post-coital test) — collection of sample and examination of wet preparation (OP) | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 |
“2215 | Examination of semen involving measurement of volume, sperm count, gram or similar stain, morphology by differential count and motility (including duration) or viability or both (SP) | 19.20 | 19.20 | 19.20 | 19.20 | 19.20 | 19.20 |
“2216 | Examination of semen involving measurement of volume, sperm count, gram or similar stain, morphology by differential count and motility (including duration) or viability or both (OP) | 14.40 | 14.40 | 14.40 | 14.40 | 14.40 | 14.40 |
“2225 | Chemical analysis of semen—analysis of one substance (SP) | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 |
“2226 | Chemical analysis of semen—analysis of one substance (OP) | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 |
“2227 | Chemical analysis of semen—analysis of two or more substances (SP) | 16.00 | 16.00 | 16.00 | 16.00 | 16.00 | 16.00 |
“2228 | Chemical analysis of semen—analysis of two or more substances (OP) | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 |
“2247 | Spermagglutinating and immobilising antibodies, test for—one test (SP) | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 |
“2248 | Spermagglutinating and immobilising antibodies, test for—one test (OP) | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 |
“2249 | Two or more tests referred to in item 2247 (SP) | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 | 12.80 |
“2250 | Two or more tests referred to in item 2248 (OP) | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 | 9.60 |
“2264 | Sperm penetrability, one or more tests for (SP) | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 |
“2265 | Sperm penetrability, one or more tests for (OP) | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 |
“2272 | Chorionic gonadotrophin, qualitative estimation of for diagnosis of pregnancy or hormone producing neoplasm by one or more methods (SP) | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 | 6.40 |
“2273 | Chorionic gonadotrophin, qualitative estimation of for diagnosis of pregnancy or hormone producing neoplasm by one or more methods (OP) | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 |
“2285 | Chorionic gonadotrophin, quantitative estimation of by serial dilution for assessment of hormone producing neoplasm by one or more methods (not associated with the service specified in item 2272) (SP) | 19.20 | 19.20 | 19.20 | 19.20 | 19.20 | 19.20 |
“2286 | Chorionic gonadotrophin, quantitative estimation of by serial dilution for assessment of hormone producing neoplasm by one or more methods (not associated with the service specified in item 2273) (OP) | 14.40 | 14.40 | 14.40 | 14.40 | 14.40 | 14.40 |
|
|
|
| Fees |
|
|
|
Item No. | Medical service | N.S.W. | Vic. | Qld | S.A. | W.A. | Tas. |
|
| $ | $ | $ | $ | $ | $ |
“Division 9—Simple Basic Pathology Tests | |||||||
“2334 | Blood count consisting of leucocyte count, erythrocyte sedimentation rate, examination of blood film (including differential leucocyte count) or any or all of haemoglobin estimation, haematocrit estimation or erythrocyte count-one procedure | 1.95 | 1.95 | 1.95 | 1.95 | 1.95 | 1.95 |
“2335 | Blood count consisting of leucocyte count, erythrocyte sedimentation rate, examination of blood film (including differential leucocyte count) or any or all of haemoglobin estimation, haematocrit estimation or erythrocyte count-two procedures | 2.95 | 2.95 | 2.95 | 2.95 | 2.95 | 2.95 |
“2336 | Blood count consisting of leucocyte count, erythrocite sedimentation rate, examination of blood film (including differential leucocyte count) or any or all of haemoglobin estimation, haematocrit estimation or erythrocyte count-three or more procedures | 3.85 | 3.85 | 3.85 | 3.85 | 3.85 | 3.85 |
“2342 | Microscopical examination of urine | 1.95 | 1.95 | 1.95 | 1.95 | 1.95 | 1.95 |
“2346 | Pregnancy test by one or more immunochemical methods | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 |
“2352 | Microscopical examination of wet film other than urine | 2.95 | 2.95 | 2.95 | 2.95 | 2.95 | 2.95 |
“2357 | Microscopical examination of gram stained film | 3.85 | 3.85 | 3.85 | 3.85 | 3.85 | 3.85 |
“2362 | Chemical tests for occult blood in faeces by reagent stick, strip, tablet or similar method | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
“2369 | Microscopical examination screening for fungi in skin, hair or nails—one or more sites | 2.95 | 2.95 | 2.95 | 2.95 | 2.95 | 2.95 |
“2374 | Mantoux test............... | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 |
“2382 | Casoni test for hydatid disease.... | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 |
“2388 | Schick test................. | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 |
“2392 | Seminal examination for presence of spermatozoa | 2.95 | 2.95 | 2.95 | 2.95 | 2.95 | 2.95”. |
NOTE
1. Notified in the Commonwealth of Australia Gazette on 14 March 1979.